跳至主要内容
临床试验/NCT01410409
NCT01410409已完成不适用

Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement. A Randomized Controlled Trial of Pain, Physical Function and Quality of Life With 12months Follow-up

Northern Orthopaedic Division, Denmark3 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
3
主要终点
Change in KOOS4 From Baseline (Knee Injury and Osteoarthritis Outcome Score)

研究概览

简要总结

The purpose of this study is to test whether surgical insertion of total knee replacement provides further improvement in quality of life, pain and function in addition to an algorithm for systematic non-surgical treatment consisting of corrective insoles, neuromuscular training, weight loss, patient education and pharmacological treatment with paracetamol, NSAIDs and Pantoprazol in patients with knee OA, collectively called the MEDIC-treatment(Medicine Exercise Diet Insoles Cognitive).

The H1-hypothesis is that surgery with insertion of TKR in addition to the MEDIC-treatment results in a greater increase in quality of life and functional capacity and greater reduction in pain than the MEDIC- treatment alone at the primary endpoint, which is follow-up 12months after the start of the treatment.

See statistical analysis plan available under "Links" for further description of the study.

详细描述

Knee osteoarthritis (OA) is the degenerative joint disease that most often requires treatment and at the same time the one associated with the greatest social costs. In addition, the disease has many personal costs and is greatly contributing to reduced functionality and autonomy of older adults.

It is recommended both nationally and internationally that the treatment of knee OA should include multiple treatment modalities. Clinical guidelines recommend that exercise, weight loss and patient education is the first step in treatment and that insoles and pharmacological treatment can be included as a supplement. If this non-surgical treatment is ineffective surgical treatment, especially surgery with insertion of total knee replacement (TKR), may be indicated. There are effects of both non-surgical treatment and TKR, but no studies exist, which examine the effect of surgery with insertion of TKR in addition to the recommended non-surgical treatment of knee OA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Knee-OA detected by x-ray (Kellgren & Lawrence grade 2 or greater)
  • Considered a candidate for TKR by the orthopedic surgeon.
  • The participant is > 18 years of age.
  • The participant can provide relevant and adequate, informed consent.

排除标准

  • Bilateral simultaneous TKR
  • Revision of prior TKR, unicompartmental knee arthroplasty or high tibial osteotomy
  • Rheumatoid arthritis
  • Mean VAS > 60mm on a 0-100mm scale
  • Investigator considers that the mental condition of the participant does not allow participation.
  • The participant must not be pregnant or plan pregnancy during the study.
  • Inability to comply with the protocol;.
  • Inadequacy in written and spoken Danish.

研究组 & 干预措施

MEDIC

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

干预措施: Neuromuscular training (NEMEX-TJR) (Other)

MEDIC

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

干预措施: Paracetamol (Drug)

MEDIC

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

干预措施: Burana (Drug)

MEDIC

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

干预措施: Pantoprazol (Drug)

MEDIC

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

干预措施: Dietary counseling (Behavioral)

MEDIC

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

干预措施: Patient education (Behavioral)

MEDIC

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

干预措施: Insoles (Other)

MEDIC + TKR

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months after a total knee replacement.

干预措施: Neuromuscular training (NEMEX-TJR) (Other)

MEDIC + TKR

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months after a total knee replacement.

干预措施: Paracetamol (Drug)

MEDIC + TKR

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months after a total knee replacement.

干预措施: Burana (Drug)

MEDIC + TKR

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months after a total knee replacement.

干预措施: Pantoprazol (Drug)

MEDIC + TKR

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months after a total knee replacement.

干预措施: Dietary counseling (Behavioral)

MEDIC + TKR

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months after a total knee replacement.

干预措施: Patient education (Behavioral)

MEDIC + TKR

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months after a total knee replacement.

干预措施: TKR (Procedure)

MEDIC + TKR

Active Comparator

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months after a total knee replacement.

干预措施: Insoles (Other)

Observational Cohort

Active Comparator

If the patient can be included, but doesn't want to participate in the randomization, the patient is offered to enter into a prospective observational cohort with the same endpoints and the same follow-up as in the randomized study. The participant can then, in consultation with his/her physician, choose whether they would like MEDIC-treatment or TKR in combination with MEDIC-treatment.

干预措施: Neuromuscular training (NEMEX-TJR) (Other)

Observational Cohort

Active Comparator

If the patient can be included, but doesn't want to participate in the randomization, the patient is offered to enter into a prospective observational cohort with the same endpoints and the same follow-up as in the randomized study. The participant can then, in consultation with his/her physician, choose whether they would like MEDIC-treatment or TKR in combination with MEDIC-treatment.

干预措施: Paracetamol (Drug)

Observational Cohort

Active Comparator

If the patient can be included, but doesn't want to participate in the randomization, the patient is offered to enter into a prospective observational cohort with the same endpoints and the same follow-up as in the randomized study. The participant can then, in consultation with his/her physician, choose whether they would like MEDIC-treatment or TKR in combination with MEDIC-treatment.

干预措施: Burana (Drug)

Observational Cohort

Active Comparator

If the patient can be included, but doesn't want to participate in the randomization, the patient is offered to enter into a prospective observational cohort with the same endpoints and the same follow-up as in the randomized study. The participant can then, in consultation with his/her physician, choose whether they would like MEDIC-treatment or TKR in combination with MEDIC-treatment.

干预措施: Pantoprazol (Drug)

Observational Cohort

Active Comparator

If the patient can be included, but doesn't want to participate in the randomization, the patient is offered to enter into a prospective observational cohort with the same endpoints and the same follow-up as in the randomized study. The participant can then, in consultation with his/her physician, choose whether they would like MEDIC-treatment or TKR in combination with MEDIC-treatment.

干预措施: Dietary counseling (Behavioral)

Observational Cohort

Active Comparator

If the patient can be included, but doesn't want to participate in the randomization, the patient is offered to enter into a prospective observational cohort with the same endpoints and the same follow-up as in the randomized study. The participant can then, in consultation with his/her physician, choose whether they would like MEDIC-treatment or TKR in combination with MEDIC-treatment.

干预措施: Patient education (Behavioral)

Observational Cohort

Active Comparator

If the patient can be included, but doesn't want to participate in the randomization, the patient is offered to enter into a prospective observational cohort with the same endpoints and the same follow-up as in the randomized study. The participant can then, in consultation with his/her physician, choose whether they would like MEDIC-treatment or TKR in combination with MEDIC-treatment.

干预措施: TKR (Procedure)

Observational Cohort

Active Comparator

If the patient can be included, but doesn't want to participate in the randomization, the patient is offered to enter into a prospective observational cohort with the same endpoints and the same follow-up as in the randomized study. The participant can then, in consultation with his/her physician, choose whether they would like MEDIC-treatment or TKR in combination with MEDIC-treatment.

干预措施: Insoles (Other)

结局指标

主要结局

Change in KOOS4 From Baseline (Knee Injury and Osteoarthritis Outcome Score)

时间窗: Primary: 12months.

The average score for four of the five KOOS subscales, covering pain, symptoms, difficulties in functions of daily living, and quality of life (KOOS4), with scores ranging from 0 (worst) to 100 (best). Between group comparisons of treatment effect (change in KOOS4 from baseline to 1 year follow-up) will be dependent on data distribution. Between group comparisons of treatment effect (change in KOOS4 from baseline to 1 year follow-up) will be dependent on data distribution. We expect the change to be normally distributed and analysis will be made using a mixed model ANOVA with subject being a random factor and visit (baseline, 3, 6 and 12 months), treatment arm (TKA + MEDIC, MEDIC) and site (Frederikshavn, Farsoe) being fixed factors. Baseline KOOS4 will be a covariate. Furthermore interactions between the fixed factors will be included in the model. P-values and 95% CI will be presented to assess superiority.

次要结局

  • Change in Timed Up & Go (TUG) From Baseline(Primary: 12months.)
  • Change in the Five Subscales of KOOS From Baseline(Primary: 12months.)
  • Change in 20-meter Walk From Baseline(Primary: 12months.)
  • Weight Change in kg From Baseline(Primary: 12months.)
  • Change in EQ-5D From Baseline(Primary: 12months.)
  • Proportion of Users of Pain Medication(Baseline and 12months.)
  • Serious Adverse Events Related to the Index Knee(Primary: 12months)

研究者

发起方
Northern Orthopaedic Division, Denmark
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验